These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2973603)

  • 1. [Probabilistic treatment with ceftazidime of severe infections in children].
    Bégué P
    Presse Med; 1988 Oct; 17(37):1985-7. PubMed ID: 2973603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of ceftazidime in severe infections in children. Review of the literature].
    Bégué P; Quinet B
    Presse Med; 1988 Oct; 17(37):1944-7. PubMed ID: 2973592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ceftazidime and probabilistic treatment of severe infections in adults].
    Potel G; Touze MD; Baron D
    Presse Med; 1988 Oct; 17(37):1981-4. PubMed ID: 2973602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ceftazidime in the treatment of 80 infectious episodes in compromised children.
    Viscoli C; Gargani G; Facco F; Mantero E; Tuo P; Giacchino R; Campelli A; Nantron M; Perlino G
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):629-34. PubMed ID: 3908333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].
    Schaison G; Leverger G; Pappo M; Chiche D
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):557-60. PubMed ID: 2200996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime therapy for serious infections.
    Bint AJ; Constable J; Patton KR; Constable FL
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():115-21. PubMed ID: 6352613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Empirical antibiotic therapy and ceftazidime].
    Modai J
    Presse Med; 1988 Oct; 17(37):1977-80. PubMed ID: 2973601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].
    Prévotat A; Leroy S; Perez T; Wallet F; Wallaert B
    Rev Mal Respir; 2010 May; 27(5):449-56. PubMed ID: 20569877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ceftazidime in the treatment of otorhinolaryngoiatric bacterial infections.
    Vellucci A; Marcucci L; Greco D; Schinaia N; Caterini A; Benedetti M
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):282-8. PubMed ID: 3298082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ceftazidime for the treatment of infections in neutropenic children].
    Leverger G; Arlet G; Bancillon A; Schaison G
    Presse Med; 1988 Oct; 17(37):1974-6. PubMed ID: 2973600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
    Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
    Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis, Pseudomonas aeruginosa, and selective decontamination.
    Dalzell AM; van Saene HK; Heaf DP
    Arch Dis Child; 1990 Dec; 65(12):1365-7. PubMed ID: 2125405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
    Principi N; Marchisio P
    J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime in the treatment of acute severe infections in children and adults.
    Păun L; Ceauşu E
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):177-84. PubMed ID: 2699410
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of intravenous ceftazidime in childhood infections].
    Kanra G; Gürsavaş M; Aydin M; Cengizlier R; Seçmeer G; Ceyhan M
    Mikrobiyol Bul; 1990 Jul; 24(3):226-36. PubMed ID: 2283973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of ceftazidime in the treatment of pediatric infections].
    Kim B; Meguro H; Arimasu O; Mashiko J; Ohnari S; Tagaya M; Sakamoto M; Fujii R
    Jpn J Antibiot; 1984 Mar; 37(3):363-76. PubMed ID: 6376850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical results of the treatment of bacterial infections in children with ceftazidime].
    Zoch-Zwierz W; Rudobielska M; Wierciński R; Winiecka W; Tomaszewska B
    Pol Tyg Lek; 1989 Apr; 44(17):390-3. PubMed ID: 2696939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.